PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML)

PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) is a topic covered in the Harrison's Manual of Medicine.

To view the entire topic, please or .

Harrison’s Manual of Medicine 20th edition provides 600+ internal medicine topics in a rapid-access format. Download Harrison’s App to iPhone, iPad, and Android smartphone and tablet. Explore these free sample topics:

-- The first section of this topic is shown below --

CLINICAL FEATURES

A progressive disorder due to infection with the JC virus, a human polyoma virus; multifocal areas of demyelination of varying size distributed throughout the CNS but sparing the spinal cord and optic nerves, with characteristic cytologic alterations in astrocytes and oligodendrocytes. Pts often present with visual deficits (45%), typically a homonymous hemianopia, and mental impairment (38%) (dementia, confusion, personality change), weakness, and ataxia. Seizures occur in ∼20% of pts. Almost all pts have an underlying immune disorder or are receiving immunosuppressive therapy. More than 80% of currently diagnosed PML cases occur in pts with AIDS; it has been estimated that up to 5% of AIDS pts will develop PML. Immunosuppressant drugs such as natalizumab have also been associated with PML.

-- To view the remaining sections of this topic, please or --

CLINICAL FEATURES

A progressive disorder due to infection with the JC virus, a human polyoma virus; multifocal areas of demyelination of varying size distributed throughout the CNS but sparing the spinal cord and optic nerves, with characteristic cytologic alterations in astrocytes and oligodendrocytes. Pts often present with visual deficits (45%), typically a homonymous hemianopia, and mental impairment (38%) (dementia, confusion, personality change), weakness, and ataxia. Seizures occur in ∼20% of pts. Almost all pts have an underlying immune disorder or are receiving immunosuppressive therapy. More than 80% of currently diagnosed PML cases occur in pts with AIDS; it has been estimated that up to 5% of AIDS pts will develop PML. Immunosuppressant drugs such as natalizumab have also been associated with PML.

There's more to see -- the rest of this entry is available only to subscribers.